بدائل البحث:
related decrease » related disease (توسيع البحث), greater decrease (توسيع البحث), related diseases (توسيع البحث)
reported case » reported cases (توسيع البحث), reported use (توسيع البحث), imported cases (توسيع البحث)
related decrease » related disease (توسيع البحث), greater decrease (توسيع البحث), related diseases (توسيع البحث)
reported case » reported cases (توسيع البحث), reported use (توسيع البحث), imported cases (توسيع البحث)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Motifs significantly enriched in decreased ATAC peaks relative to unchanged ATAC peaks at 30 minutes.
منشور في 2024"…<p>Motifs significantly enriched in decreased ATAC peaks relative to unchanged ATAC peaks at 30 minutes.…"
-
8
Characteristics of adolescents with T2D cases reporting ADRs to metformin in FAERS.
منشور في 2025الموضوعات: -
9
-
10
-
11
Henoch-Schönlein purpura nephritis associated with monoclonal gammopathy of renal significance: a case report
منشور في 2019"…The Henoch-Schönlein purpura nephritis (HSPN) that cannot be relieved by treatment with glucocorticoid and immunosuppressive agents suggests the presence of monoclonal gammopathy in adult patients. The present study reports on a single case of HSPN associated with IgA-κMGRS. …"
-
12
-
13
-
14
Data Sheet 1_Case report: Achieving significant tumor reduction in advanced pancreatic adenocarcinoma.docx
منشور في 2024"…However, certain genetic profiles, such as BRCA1/2 mutations, high tumor mutational burden (TMB), or microsatellite instability-high (MSI-H), may enhance sensitivity to these therapies. This report presents two cases of advanced pancreatic cancer with BRCA1/2 mutations treated with a combination of chemotherapy and immune checkpoint inhibitors. …"
-
15
Multivariate logistic regression of significant variables stratified by age.
منشور في 2025الموضوعات: -
16
-
17
-
18
-
19
Data Sheet 1_Case Report: Efgartigimod demonstrates significant clinical efficacy in double seropositive myasthenia gravis: a case report of a rare variant and analysis of pathomechanisms.pdf
منشور في 2025"…Currently, no standardized therapeutic protocol exists for DSP-MG due to its scarcity and clinical heterogeneity. Herein, we report a case of a 68-year-old female patient with DSP-MG who showed significant clinical improvement during an acute exacerbation after treatment with the FcRn antagonist efgartigimod, following the failure of conventional therapy. …"
-
20